Shots:
- Merck has reorganized its Human Health division into two units: Oncology, and Specialty, Pharma & Infectious Diseases, to sharpen commercial execution & support a growing portfolio of launches across diverse therapeutic areas
- Jannie Oosthuizen has been appointed EVP & President, Oncology & MSD International, while Brian Foard will serve as EVP & President, Specialty, Pharma & Infectious Diseases
- The restructuring aligns with Merck’s robust late-stage pipeline, which incl. ~80 P-III trials & >20 anticipated growth drivers over the next few years, positioning the company to sustain oncology leadership & accelerate commercialization across specialty & infectious diseases
Ref: Merck | Image: Merck | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
